Human Genome Epidemiology Literature Finder
Records 1 - 17 (of 17 Records) |
Query Trace: Lung Neoplasms and meta-analysis and TP53[original query] |
---|
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 2003 Jul 18 (4): 377-85. Matakidou A, Eisen T, Houlston RS |
TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis. International journal of cancer. Journal international du cancer 2009 Dec 125 (12): 2903-11. Yan Lili, Zhang Deqiang, Chen Chengwen, Mao Yumin, Xie Yi, Li Yao, Huang Yan, Han Baoh |
A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects. Lung cancer (Amsterdam, Netherlands) 2009 Oct 66 (1): 15-21. Li Yan, Qiu Li-Xin, Shen Xiao-Kun, Lv Xiao-Jing, Qian Xiao-Ping, Song Yo |
Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. International journal of cancer. Journal international du cancer 2011 Aug 129 (4): 920-30. Francisco Guilherme, Menezes Paulo Rossi, Eluf-Neto José, Chammas Rog |
Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis. Carcinogenesis 2010 Apr 31 (4): 643-7. Hu Zheng, Li Xiang, Qu Xincai, He Yungang, Ring Brian Z, Song Enmin, Su |
Association between the p73 exon 2 G4C14-to-A4T14 polymorphism and cancer risk: a meta-analysis. DNA and cell biology 2012 Feb 31 (2): 230-7. Hu Yi, Jiang Lan, Zheng Jian, You Yonghe, Zhou Yifeng, Jiao Shuncha |
Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites. Journal of cellular and molecular medicine 2013 Jul 17 (7): 873-8. Guan Xiaoxiang, Wang Li-E, Liu Zhensheng, Sturgis Erich M, Wei Qing |
The association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects. Lung 2013 Aug 191 (4): 369-77. Qiao Qian, Hu Weig |
Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis. Molecular biology reports 2013 Nov . Ye XH, Bu ZB, Feng J, Peng L, Liao XB, Zhu XL, Sun XL, Yu HG, Yan DF, Yan SX |
The TP53 codon 72 Pro/Pro genotype may be associated with an increased lung cancer risk in North China: an updated meta-analysis. International journal of clinical and experimental medicine 2015 8 (3): 3120-6. Wang Xin, Hao Li-Ran, Yue K |
TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: Evidence from a meta-analysis. Molecular and clinical oncology 2016 Dec 5 (6): 705-713. Gu Jincui, Zhou Yanbin, Huang Lixia, Ou Weijun, Wu Jian, Li Shaoli, Xu Junwen, Feng Jinlun, Liu Bao |
The prognostic impact of TP53 comutation in EGFR mutant lung cancer patients: a systematic review and meta-analysis. Postgraduate medicine 2019 Feb . Zhang Rui, Tian Panwen, Chen Bojiang, Wang Tao, Li Weim |
Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis. Asian Pacific journal of cancer prevention : APJCP 2020 (6): 1511-1519. Jafrin Sarah, Aziz Md Abdul, Anonna Shamima Nasrin, Akter Tahmina, Naznin Nura Ershad, Reza Sharif, Islam Mohammad Safiq |
Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis. BMC cancer 2020 4 20 (1): 328. Qin Kang, Hou Helei, Liang Yu, Zhang Xiaoch |
Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis. Pathology, research and practice 2021 Jul 224 153551. Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih |
The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis. Vavilovskii zhurnal genetiki i selektsii 2021 5 24 (7): 777-784. Bulgakova O, Kussainova A, Bersimbaev |
Concurrent TP53 mutations predict a poor prognosis of EGFR-mutant NSCLCs treated with TKIs: An updated systematic review and meta-analysis. Oncology letters 2022 Nov 24 (5): 384. Lan Bo, Zhao Na, Du Kang, Leng Baola |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: